Simplex Trading
APGE icon

Simplex Trading’s Apogee Therapeutics APGE Stock Holding History

Simplex Trading’s Portfolio APGE Stock Details APGE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$513K Buy
6,100
+1,500
+33% +$109K ﹤0.01% 3229
2025
Q4 		$347K Sell
4,600
-7,100
-61% -$447K ﹤0.01% 3675
2025
Q3 		$464K Sell
11,700
-7,000
-37% -$267K ﹤0.01% 3922
2025
Q2 		$812K Buy
18,700
+12,200
+188% +$464K ﹤0.01% 2991
2025
Q1 		$242K Buy
+6,500
New +$251K ﹤0.01% 4117
2024
Q4 		– Sell
-200
Closed -$11K – 8436
2024
Q3 		$11K Buy
+200
New +$9.58K ﹤0.01% 7103

Other funds holding APGE

T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
VA
VR Adviser New York $2.68B AUM 422.73% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
DCM
Driehaus Capital Management Chicago, Illinois $13.6B AUM 173.98% 1-Year Est. Return

Simplex Trading's APGE Position: Q1 2026 in Review

Simplex Trading increased its Apogee Therapeutics (APGE) stake by 24% in Q1 2026, buying an estimated $1.09M and bringing the position to 77,808 shares worth $6.55M. The position accounts for ﹤0.01% of the portfolio, ranked #925.

Simplex Trading first reported a position in APGE in Q3 2024 and has held it in 4 quarters since. 224 funds tracked by Wall St. Rank hold APGE as of Q1 2026.

  • Simplex Trading held 77,808 shares of Apogee Therapeutics worth $6.55M as of Q1 2026.
  • Simplex Trading bought 15,009 Apogee Therapeutics shares in Q1 2026, an estimated $1.09M.
  • Apogee Therapeutics made up ﹤0.01% of Simplex Trading's portfolio in Q1 2026, its #925 holding.
  • Simplex Trading first reported a position in Apogee Therapeutics in Q3 2024 and has held it in 4 quarters since.
  • 224 funds tracked by Wall St. Rank held Apogee Therapeutics as of Q1 2026.

Based on Simplex Trading's 13F filing for Q1 2026, filed 14 May 2026.